Congenital Adrenal Hyperplasia Market Share Global Overview Business Growth Sales Revenue and Competitive Landscape
Congenital Adrenal
Hyperplasia Market Scenario
A congenital adrenal hyperplasia is a group of
genetic conditions limiting hormone production in the adrenal glands. The exact
cause of the disorder is still unknown, however, genetic disorders and other
external factors are thought to be responsible for causing this disorder.
A wide range of drugs are available for the treatment
of this disorder, however, no precise treatment is available to cure the
disease. Increasing prevalence of congenital adrenal hyperplasia and genetic
disorders has boosted the growth of the market. Many government organization is
helping the manufacturer by providing funds for research.
The global Congenital Adrenal Hyperplasia Market is
expected to grow at a CAGR of ~ 7.1 %
during the forecast period 2017-2023.
Get Free Sample at https://www.marketresearchfuture.com/sample_request/4946
Additionally, increasing need for better treatment,
and increasing government support has driven the global market. However,
limited and high cost of treatment options may sustain the growth of the market
over the assessment period. Recent advances in the molecular genetic analysis
have created a huge opportunity for the market development.
Congenital Adrenal
Hyperplasia Market Segmentations
The global congenital adrenal hyperplasia market is
segmented on the basis of types, diagnosis & treatment and end users.
On the basis of types, the market is
segmented into classic CAH, and non-classic CAH.
On the basis of
diagnosis & treatment, the market is segmented into diagnosis
and treatment. Diagnosis is further segmented into amniocentesis, chorionic
villus sampling, blood and urine tests, gene testing, physical exam, and
others. Treatment is sub-segmented into medications and surgery. Medications are
again segmented into glucocorticoids, mineralocorticoids, salt supplements, and
others.
On the basis of end
users,
the market is segmented into hospital, clinics and others.
Key Players
Major Key Vendors of the Industry players in the
market are
·
Neurocrine Biosciences Inc. (U.S.)
·
Fusion IP plc (U.K)
·
Novartis AG (Switerzland)
·
Mitsubishi Chemical Holdings Corporation
(Japan)
·
Johnson & Johnson (U.S.)
·
GlaxoSmithKline Plc (U.S.)
·
Cadila healthcare (India)
·
Sanofi (France)
·
Macleods Pharmaceuticals (India)
·
GlaxoSmithKline Plc. (U.K)
·
Allergan (Ireland)
·
Abbott (U.S.)
·
F. Hoffmann-La Roche Ltd. (Switzerland)
·
Eli Lilly and Company (U.S.)
·
AstraZeneca Plc. (U.K)
·
and Merck & Co. Inc. (U.S.)
Access
Complete Premium Research Report at https://www.marketresearchfuture.com/reports/congenital-adrenal-hyperplasia-market-4946
Congenital
Adrenal Hyperplasia Market Regional Analysis
The
Americas dominate the global congenital adrenal hyperplasia market owing to the
increasing number of patients with congenital adrenal hyperplasia, and genetic
disorders. Due to rapidly increasing patient population, governments have
started supporting the manufacturers for the development of new and better
drugs. Additionally, well-developed technology, high healthcare expenditure,
and strong government support for research & development have fueled the
growth of the market in this region.
Europe
commands the second largest market for congenital adrenal hyperplasia which is
followed by Asia Pacific. Availability of funds, increasing need for better
treatment options and strong government support drive the growth of the market
in Europe. Germany, France & U.K holds the major share in the Europe
market.
Asia
Pacific is the fastest growing congenital adrenal hyperplasia market owing to
the increasing number of patients suffering from genetic disorders and presence
of a huge opportunity for the development of the market. Additionally, rapidly
growing economies and increasing healthcare expenditure will fuel the growth of
the market.
On
the other hand, the Middle East & Africa holds the least share of the
market owing to less availability of funds, limited availability of medical
facilities, and poor political conditions in Africa. The Middle East region
holds the major share in the market owing to well-developed technology, and
high healthcare expenditure. On the other hand, Africa region shows the fastest
growth due to the availability of opportunities for the market growth.
Ask for an Amazing
Discount at https://www.marketresearchfuture.com/check-discount/4946
At Market
Research Future (MRFR), Our market research studies by products, services,
technologies, applications, end users, and market players for global, regional,
and country level market segments, enable our clients to see more, know more,
and do more, which help to answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment